New Q Exactive HF-X Orbitrap mass spectrometer enables scientists to advance disease research and drug discovery   INDIANAPOLIS – ASMS 2017 – Scientists studying complex protein samples can now take advantage of a new high-performing Orbitrap mass spectrometer designed to quickly and consistently produce superior data quality for challenging workflows across life science research and […]

LANSING, Mich. — Neogen Corporation (NASDAQ: NEOG) has expanded its comprehensive line of food allergen test kits to include a test for sesame that can be used to screen samples at a set level, or provide precise quantitative results. Neogen’s new Veratox® for Sesame Allergen test provides results in just 30 minutes after extraction. The new test can […]

INDIANAPOLIS — ASMS 2017 – Thermo Fisher Scientific Inc., the world leader in serving science, and BIOCRATES Life Sciences AG, a global leader in metabolic phenotyping, today launched a ready-to-use kit for accurate and confident metabolic phenotyping on high resolution mass spectrometry instruments. As part of a co-marketing agreement, the companies will jointly promote and market the combined […]

INDIANAPOLIS — ASMS 2017 – Thermo Fisher Scientific Inc., the world leader in serving science, today announced a co-marketing agreement with Biognosys AG, leader in next-generation proteomics, to provide a comprehensive, efficient workflow to enable library creation and data processing for Data-Independent Acquisition (DIA) studies, through the combined use of Orbitrap mass spectrometers and Spectronaut Pulsar software. […]

New proteins will advance research in testing and treating the West Nile Virus globally.   New York — Enterprise Ireland, the Irish government agency for the promotion of international trade by Irish companies, today celebrated the success of client company Aalto Bio Reagents in launching its first-to-market native and recombinant West Nile virus (WNV) proteins for […]

NEW YORK and HILDEN, Germany – Bristol-Myers Squibb Company (NYSE: BMY) and QIAGEN(NASDAQ: QGEN; Frankfurt Prime Standard: QIA) have signed an agreement to explore the use of next-generation sequencing (NGS) technology to develop gene expression profiles (GEPs) as  predictive or prognostic tools for  use with Bristol-Myers Squibb novel immuno-oncology (I-O) therapies in cancer treatment. This will […]

Option to add new biomarkers for microsatellite instability (MSI) and mismatch repair (MMR) to QIAGEN’ s NGS panels Hilden, Germany, and Germantown, Maryland – QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced it has received a worldwide license from The Johns Hopkins University for biomarkers that have been shown to play key roles in […]

Agreement Accelerates the Development of Tests to Help Assess Risk of Disease Recurrence in Women with Early-Stage Breast Cancer SANTA CLARA, Calif. & IRVINE, Calif.–Agilent Technologies Inc. (NYSE: A) and Agendia, Inc. today jointly announced an agreement to expand their relationship to include the development of an RNA-Seq kit version of Agendia’s currently marketed MammaPrint […]

Omaha, NE – Streck, Inc. and Nordic BioSite, a life sciences products distributor in Sweden, Finland, Denmark and Norway, have signed a distribution agreement for Streck’s full portfolio of cell stabilization, molecular and core products. Streck’s cell stabilization products include Cell-Free DNA Urine Preserve, a formaldehyde-free liquid reagent that stabilizes cell-free DNA (cfDNA) in urine; […]

Cambridge, UK: Syngene, a world-leading manufacturer of image analysis solutions, today announced its G:BOX Chemi XX6 multi-application imager is being utilised by scientists at a top University in Germany to speed up analysis of genes and proteins associated with neurodegenerative conditions. Researchers at the German University are using a G:BOX Chemi XX6 multi-application imager to […]